Skip to content

Source filing unavailable

Q4 2010 · —

derived · Computed from the longer spans the company filed.

Revenue—
Net income—
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Cash Flowderived-$2,749,635—
Free Cash Flowderived-$2,797,976—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q4 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR